Pediatric ECMO Research: The Case for Collaboration

Melania M Bembea1, Aparna Hoskote2, Anne-Marie Guerguerian3

  • 1Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Frontiers in Pediatrics
|September 26, 2018
PubMed

Insights

Extracorporeal membrane oxygenation (ECMO) use in critically ill children has grown, but research faces challenges. Future multicenter studies are needed to advance pediatric ECMO care.

Area of Science:

  • Pediatric Critical Care Medicine
  • Cardiopulmonary Support
  • Medical Technology Research

Background:

  • Pediatric extracorporeal membrane oxygenation (ECMO) use has significantly increased over the past decade.
  • Indications and case complexity for pediatric ECMO have expanded beyond the neonatal period.
  • Despite increased use, no randomized controlled trials exist for non-neonatal pediatric ECMO interventions.

Purpose of the Study:

  • To review the history of clinical research in pediatric ECMO.
  • To discuss the methodological challenges in conducting pediatric ECMO research.
  • To explore opportunities for future collaborative research in pediatric ECMO.

Main Methods:

  • Literature review of historical clinical research in pediatric ECMO.
  • Discussion of challenges including patient heterogeneity, technological advancements, and inter-institutional variability.
  • Exploration of existing infrastructure for multicenter research collaborations.

Main Results:

  • Significant growth in pediatric ECMO utilization and complexity noted.
  • Key methodological hurdles identified: age/diagnosis heterogeneity, rapid technological evolution, enrollment feasibility, and management variability.
  • Opportunities for future research through existing multicenter, multi-network infrastructure highlighted.

Conclusions:

  • Conducting randomized controlled trials in pediatric ECMO is complex but crucial for evidence-based practice.
  • Addressing methodological challenges is essential for advancing the field.
  • Collaborative research efforts are vital for improving outcomes for critically ill children requiring ECMO.

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
371
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
264
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
311
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
233
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
301
Polygenic Traits01:18

Polygenic Traits

When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
69.1K